U.S. market Closed. Opens in 1 day 5 hours 33 minutes

ROIV | Roivant Sciences Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-31
Revenue124.80M61.28M55.29M23.80M67.69M
Cost of Revenue27.96M13.13M8.97M2.06M1.13M
Gross Profit96.83M48.15M46.32M21.74M66.56M
Operating Expenses-4.13B1.22B1.40B1.09B598.98M
Selling, General & Admin675.04M600.51M775.03M259.88M335.77M
Research & Development501.74M525.22M483.04M236.63M263.22M
Other Operating Expenses-5.32B97.75M139.89M596.13MN/A
Operating Income4.24B-1.18B-1.35B-1.07B-532.42M
Other Expenses / Income11.41M-49.52M427.89M172.35M-28.56M
Before Tax Income4.25B-1.22B-923.75M-898.55M-560.99M
Income Tax Expenses22.22M5.19M369.00K1.69M7.12M
Net Income4.35B-1.01B-845.26M-809.23M1.20B
Interest Expenses34.78M27.97M7.04M2.81M7.68M
Basic Shares Outstanding783.25M712.79M669.75M684.79M215.35M
Diluted Shares Outstanding831.05M712.79M669.75M684.79M215.35M
EBITDA4.31B-1.18B-916.71M-895.74M-553.30M
EBITDA Margin3,453.86%-1,922.34%-1,658.12%-3,764.40%-817.42%
EBIT4.41B-975.87M-837.85M-804.74M1.22B
EBIT Margin3,530.53%-1,592.48%-1,515.49%-3,381.97%1,795.44%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙